Latest filing published 03 Mar 2026 for Aura Biosciences, Inc..
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Pinos Elisabet de los, listed as chief executive, appears in our data through filings on Aura Biosciences, Inc. shares, published by SEC (Form 4). Between 28 October 2021 and 2 March 2026, the trades on record add up to 22 filings.
On the market, this insider has only sold: 11 sales, €1.3M in total. The rest of the record consists of 6 share grants and 4 option exercises. In 2026 alone, the filings show no purchases and 2 sales.
The newest entry dates from 3 March 2026: a share grant, in Aura Biosciences, Inc. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
20 of 20 declarations